"Certara provided valuable support in refining dosing strategies and facilitating regulatory discussions for Givinostat. Their contributions helped us navigate the submission process effectively. We appreciate the collaboration and look forward to working together again."

"The patient group was small and contained a limited variety of patient characteristics, hence dosage standardization (for inclusion in the drug package insert) would have been impossible without the PPK model-based simulation technique. We worked with Certara to resolve this problem. Certara’s lead consultant, Dr. Mayumi Hasegawa, quickly understood our …